Page last updated: 2024-09-05

erlotinib hydrochloride and Cancer of Spleen

erlotinib hydrochloride has been researched along with Cancer of Spleen in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, AB; Lam, KC; Lee, KW; Lo, AW	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Cancer of Spleen

Article	Year
Erlotinib in metastatic bronchopulmonary mucoepidermoid carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:12 Topics: Adult; Carcinoma, Mucoepidermoid; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Pleural Neoplasms; Protein Kinase Inhibitors; Quinazolines; Splenic Neoplasms	2011

Article

Year

Erlotinib in metastatic bronchopulmonary mucoepidermoid carcinoma.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:12

Topics: Adult; Carcinoma, Mucoepidermoid; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Pleural Neoplasms; Protein Kinase Inhibitors; Quinazolines; Splenic Neoplasms

2011